Plasma Adsorption in Patients With Confirmed COVID-19

NCT04358003 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Failure
ARDS

Interventions

DEVICE: Marker Therapeutics D2000 Cartridge (D2000) for use with the Spectra Optia® Apheresis System (Optia SPD Protocol)

Sponsor

Marker Therapeutics AG

Collaborators

[object Object]